Products

Enzymes for Research, Diagnostic and Industrial Use

Products
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Inhibitors

Enzyme inhibitors are molecules that interact in certain ways with the enzyme to prevent it from functioning in a normal manner. They can alter the catalytic action of the enzyme and consequently slow down, or even stop catalysis. Inhibitors can act in various modes when interacting with the enzyme: reversible or irreversible inhibition, covalent binding or non-covalent binding, as well as specific or nonspecific inhibition. Based on the inhibition kinetics, enzyme inhibition can be categorized into three major types: competitive inhibition, non-competitive inhibition, and uncompetitive inhibition.

Competitive Inhibition

Competitive inhibition occurs when an inhibitor and a substrate both tend to bind to the enzyme in an exclusive manner. A competitive inhibitor could be any compound that closely resembles the chemical structure and molecular geometry of the substrate. The inhibitor competes for the same active site with the substrate molecule. Upon binding, interactions between the inhibitor and the enzyme may be strong in the active site, but no reaction would happen because the inhibitor does not carry the same chemical reactivity. As a result, the inhibitor is "stuck" on the enzyme and prevents any substrate molecules from reacting with the enzyme, and thus the reaction rate is decreased. However, a competitive inhibition is usually temporary and reversible. Therefore, the level of inhibition depends upon the relative concentrations of the substrate and inhibitor, as well as the relative affinities of the inhibitor and substrate to the active site, since they are competing for places in the enzyme active sites.

Non-Competitive Inhibition

Non-competitive inhibitors bind to the enzyme regardless of whether the active site is already occupied by the substrate. In fact, the enzyme could be in complexes with either the substrate or inhibitor, or both during non-competitive inhibition. A common form of non-competitive inhibition is called allosteric inhibition, where the inhibitor does not bind to the active site, but the allosteric site. Binding to an allosteric site distorts the 3-dimensional tertiary structure of the enzyme, such that it can no longer catalyze a reaction. There are also other mechanisms of non-competitive inhibition than allosteric inhibition. For example, both the substrate and inhibitor could bind to the active site at the same time. Some non-competitive inhibitors are irreversible and permanent because they denature the enzymes effectively. However, there are also non-competitive inhibitors reversibly and non-permanently stops the enzymatic reaction, which are vital in controlling metabolic functions in organisms.

Uncompetitive Inhibition

Uncompetitive inhibition is not commonly seen. An uncompetitive inhibitor binds to the enzyme and enhances the binding affinity of the substrate, but the resultant enzyme-inhibitor-substrate complex undergoes reaction to form the product very slowly. It should be noted that uncompetitive inhibition requires the formation of an enzyme-substrate complex prior to binding to the inhibitor. To the contrary, non-competitive inhibition can occur with or without the substrate present.

Application of the Enzyme Inhibitors

Enzyme inhibitors play important roles in pharmaceutical and biochemical industries. They can be widely used in metabolic control, as metabolic poisons and medicines. For example, many poisons work by inhibiting the action of enzymes involved in metabolic processes, which defends a plant or animal against predators. In addition, some enzyme inhibitors can be used as drugs in the treatment of various diseases. Some antimicrobial drugs are enzyme inhibitors that deactivate the enzymes that are needed for the survival of pathogens.

Creative Enzymes gladly supply various enzyme inhibitors of premier grade to the customers. We persist in being the most reliable supplier for enzyme products in the global market. Today, Creative Enzymes is a leading company in enzymes and enzyme-related products, and is well known for the high level of customer satisfaction. We deliver the products in a momentary span of time from order placement to final delivery. Our prompt service, dedicated customer care, and reliable approaches have made us the most preferred vendor.

Catalog Product Name EC No. CAS No. Source Price
CEI-1078 Fludarabine (Fludara) 21679-14-1 Inquiry
CEI-1077 Cucurbitacin I 2222-07-3 Inquiry
CEI-1076 Cercosporamide 131436-22-1 Inquiry
CEI-1075 BMS-911543 1271022-90-2 Inquiry
CEI-1074 S-Ruxolitinib (INCB018424) 941685-37-6 Inquiry
CEI-1073 CEP-33779 1257704-57-6 Inquiry
CEI-1072 ZM 39923 HCl 1021868-92-7 Inquiry
CEI-1071 WP1066 857064-38-1 Inquiry
CEI-1070 Tofacitinib (CP-690550,Tasocitinib) 477600-75-2 Inquiry
CEI-1068 JAK3 Inhibitor VII, AD412 796041-65-1 Inquiry
CEI-1067 JAK3 Inhibitor VI 856436-16-3 Inquiry
CEI-1066 JAK3 Inhibitor V 4452-06-6 Inquiry
CEI-1065 JAK3 Inhibitor, Negative Control 153437-07-1 Inquiry
CEI-1064 JAK3 Inhibitor IV 58753-54-1 Inquiry
CEI-1063 JAK2 Inhibitor V, Z3 195371-52-9 Inquiry
CEI-1062 JAK2 Inhibitor III, SD-1029 118372-34-2 Inquiry
CEI-1061 JAK2 Inhibitor II 1837-91-8 Inquiry
CEI-1060 InSolution™ JAK Inhibitor I 457081-03-7 Inquiry
CEI-1059 NSC-687852 (b-AP15) 1009817-63-3 Synthetic Inquiry
CEI-1058 17-GMB-APA-GA Hsp90 Synthetic Inquiry
CEI-1057 MAPKII Kinase Inhibitor (Hsp25 kinase inhibitor) Hsp25 Synthetic Inquiry
CEI-1056 Hexyl-4-pentynoic Acid 96017-59-3 Synthetic Inquiry
CEI-1055 MLN-4924 905579-51-3 Synthetic Inquiry
CEI-1054 Triacsin C 76896-80-5 Synthetic Inquiry
CEI-1052 Herbimycin A 70563-58-5 Synthetic Inquiry
CEI-1051 BC-11-38 686770-80-9 Synthetic Inquiry
CEI-1050 Xanthohumol 6754-58-1 Synthetic Inquiry
CEI-1049 SMER3 67200-34-4 Synthetic Inquiry
CEI-1048 Pifithrin mu 64984-31-2 Synthetic Inquiry
CEI-1047 Hypericin 548-04-9 Synthetic Inquiry